» Articles » PMID: 12373555

Early Molecular Events in the Development of the Diabetic Cardiomyopathy

Overview
Journal Amino Acids
Specialty Biochemistry
Date 2002 Oct 10
PMID 12373555
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Oxidative damage to DNA has been well documented in cardiac cells isolated from diabetic patients and rats with streptozotocin-induced diabetes mellitus (DM). This study evaluates possible molecular mechanisms for early events in the development of DM-induced cardiomyopathy.

Methods: To analyze the mechanism of overexpression of p21(WAF1/CIP1) and inhibition of cyclin D(1) expression in cardiomyocytes of diabetic rats we examined the methylation status of these genes by MS-PCR and assessed the possibility of epigenetic control of their expression.

Results: We found that the steady-state expression of both genes is influenced by their methylation status, as an epigenetic event, of their 5'-flanking regions upon development of diabetes.

Conclusions: Oxidative damage contributes to the development of cardiomyopathy via p53-dependent activation of cardiac cell death. This pathway includes de novomethylation of the P53-inducible p21(WAF1/CIP1)-gene encoding a protein which binds to and inhibits a broad range of cyclin-cyclin-dependent kinase complexes.

Citing Articles

Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.

Jazieh C, Arabi T, Asim Z, Sabbah B, Alsaud A, Alkattan K Front Endocrinol (Lausanne). 2024; 15:1295967.

PMID: 38323108 PMC: 10845351. DOI: 10.3389/fendo.2024.1295967.


Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.

Cai L, Tan Y, Holland B, Wintergerst K Cardiovasc Toxicol. 2024; 24(2):71-84.

PMID: 38321349 PMC: 11517829. DOI: 10.1007/s12012-024-09836-7.


Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes.

Ryaboshapkina M, Ye R, Ye Y, Birnbaum Y Cardiovasc Drugs Ther. 2023; 39(1):43-61.

PMID: 37914900 DOI: 10.1007/s10557-023-07517-1.


Epigenetics of methylation modifications in diabetic cardiomyopathy.

Hao J, Liu Y Front Endocrinol (Lausanne). 2023; 14:1119765.

PMID: 37008904 PMC: 10050754. DOI: 10.3389/fendo.2023.1119765.


Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy.

da Silva J, Goncalves R, Vasques J, Rocha B, Nascimento-Carlos B, Montagnoli T Cells. 2022; 11(2).

PMID: 35053356 PMC: 8773977. DOI: 10.3390/cells11020240.